Aurinia Pharmaceuticals AUPH Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's deferred tax assets and other non-current assets?
- Aurinia Pharmaceuticals (AUPH) reported deferred tax assets and other non-current assets of $93K in Q1 2026.
- How has Aurinia Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Aurinia Pharmaceuticals's deferred tax assets and other non-current assets decreased by 88.7% year-over-year, from $823K to $93K.
- What is the long-term trend for Aurinia Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's deferred tax assets and other non-current assets has grown at a -17.7% compound annual growth rate (CAGR), from $247K to $93K.